This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Should You Buy Stocks Going into This Earnings Season?
by Sejuti Banerjea
Stick to tried and tested Zacks methodology this earnings season for valuable pointers as significant uncertainties remain.
Why the Earnings Surprise Streak Could Continue for Danaher (DHR)
by Zacks Equity Research
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Danaher Restructure Debt With Senior Notes Issue & Redemption
by Zacks Equity Research
Danaher (DHR) issues senior notes worth $1 billion and uses proceeds to redeem Euro-denominated senior notes. The actions are likely to help in restructuring its debt profile.
3 Top Stocks From the Booming Diversified Operations Industry
by Payal Jalan
Notwithstanding the pandemic headwinds, the Zacks Diversified Operations industry seems to be leveraging benefits from the demand surge in the personal safety, medical equipment and defense markets. Three stocks, DHR, ITT and RAVN, are the likely outperformers from the sector.
ITT vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ITT vs. DHR: Which Stock Is the Better Value Option?
Nike, OrganiGram, Thermo Fisher, Danaher Corp and Agilent Tech highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Nike, OrganiGram, Thermo Fisher, Danaher Corp and Agilent Tech highlighted as Zacks Bull and Bear of the Day
Danaher (DHR) Prices Public Offering of $1B Senior Notes
by Zacks Equity Research
Danaher (DHR) prices $1 billion worth of senior note offerings. The net proceeds will be used for satisfying general corporate purposes.
3 Picks to Ride the Coronavirus-Led Strength in Lab Plastic Space
by Urmimala Biswas
These laboratory equipment suppliers' fate does not depend on the end result of the R&D outcomes of the drug and vaccine makers.
The Truth About Market Timing - September 29, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Danaher (DHR) Gains 19% in 3 Months: What's Driving It?
by Zacks Equity Research
Danaher (DHR), with a 19% rise in the past three months, benefits from core sales growth opportunities in Diagnostics and Life Sciences segments, innovation efforts, and shareholder-friendly policies.
General Electric Completes Gas Turbine Project in Nigeria
by Zacks Equity Research
General Electric's (GE) gas turbine rehabilitation project at NDPHC's 3 power plants will secure and restore the supply of up to 360-MW of electricity. It receives certification for its GE9X engine.
Honeywell's (HON) Board Okays 3.3% Hike in Dividend Rate
by Zacks Equity Research
Honeywell (HON), in sync with its shareholder-friendly policies, hikes the annual dividend rate by 3.3% or 12 cents per share.
3 Conglomerates to Shine Despite Pandemic-Led Uncertainties
by Payal Jalan
Amid the pandemic-stricken operating environment, conglomerates are benefiting from growth options within the defense, medical equipment, personal safety and other markets. We bring forth three suitable investment picks from the sector.
Bear of the Day: Mesa Labs (MLAB)
by Kevin Cook
Growth rates have stalled for this small-cap provider of quality control instruments for the medical sector
Honeywell (HON) Displays Bright Prospects, Headwinds Persist
by Zacks Equity Research
Honeywell (HON) stands to gain from its strong defense and space businesses, cost-control actions and shareholder friendly policies. High debt profile poses a concern.
General Electric Arm Wins Wind Turbine Deal From Invenergy
by Zacks Equity Research
General Electric (GE) to offer 187 units of onshore wind turbines for Invenergy's three wind farms.
Protect Your Portfolio From Volatility With 6 Low-Beta Picks
by Nalak Das
We have narrowed down our search to six large-cap low-beta stocks. These companies have well established business model, robust liquidity and recognized brand name.
GE Clinches Multiple Contracts, Provides Free Cash Flow View
by Zacks Equity Research
General Electric (GE) to offer pumped storage technology for the Kundah hydropower plant in India. It inks a deal with BKK in Norway. It offers an update on the company's free cash flow expectations.
3M (MMM) Sales Rise Y/Y in August, Q3 Projections Impressive
by Zacks Equity Research
3M's (MMM) sales performance in August is driven by acquisitions/divestitures impact and forex gains, partially offset by the adverse impacts of lower business days. Q3 outlook for sales is promising.
General Electric Wins Onshore Wind Turbine Deal in Austria
by Zacks Equity Research
General Electric's (GE) Renewable Energy will soon deliver 30 units of 5.5 MW onshore wind turbines to PUSPOK Group. Also, it enters into a multi-year service agreement with the company.
General Electric Clinches HA Gas Turbine Contract in Russia
by Zacks Equity Research
General Electric (GE) to offer gas turbine technology for the Zainskaya State District Power Plant's project. Separately, it inks energy management deal with Damen Schelde Naval Shipbuilding.
The Keys to Successfully Timing the Markets - September 03, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Danaher (DHR) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $205.64 in the latest trading session, marking a +0.61% move from the prior day.
Reasons Why Danaher (DHR) is an Attractive Investment Option
by Zacks Equity Research
Danaher (DHR) to benefit from solid product offerings, innovation efforts, buyouts and divestments, and shareholder-friendly policies. Its third-quarter organic sales growth prospects are encouraging.
3M (MMM) Unveils Virtual Assistant Technology for Epic Users
by Zacks Equity Research
3M (MMM) introduces 3M M*Modal virtual assistant technology for Epic customers, which will make the process of electronic health record documentation simpler, faster and more effective for clinicians.